Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Efficacy and safety of combined therapy with synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: Systematic literature review
Jaime Calvo Alén; Trinidad Pérez; Susana Romero Yuste; Iván Ferraz-Amaro; Juan José Alegre Sancho; José Antonio Pinto Tasende; Francisco Maceiras Pan; Juan Carlos Quevedo; M. Vanesa Hernández-Hernández; Cristina Hidalgo Calleja; Alejandro San Martín Álvarez; María Isabel Tevar Sánchez; Raimon Sanmartí;
Reumatol Clin. 2020;16P1:324-32
Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis
Jesús Tornero-Molina; Mercedes Alperi-López; Ivan Castellví; Juan José de Agustín-de Oro; Alejandro Escudero; Rosario García-Vicuña; Miguel Ángel González-Gay; Cristina Hidalgo; Esteban Rubio; Raimon Sanmartí; Núria Casamira; Jaime Calvo-Alén;
Reumatol Clin. 2022;18:33-41
Treat-to-target strategy in patients with rheumatoid arthritis: Audit of adherence from real world clinical data
José-Luis Andréu; María Auxiliadora Martín; Héctor Corominas; José Javier Pérez-Venegas; José Andrés Román-Ivorra; Fernando Sánchez-Alonso; Ángel Gil de Miguel;
Reumatol Clin. 2021;17:212-4